Okami Medical gets expanded FDA indication for LOBO

The U.S. FDA granted Okami Medical an expanded indication for its LOBO Vascular Occlusion System, extending use into peripheral veins. The company said the change broadens embolization options for venous conditions including pelvic venous disease and portal hypertension.